Business Description
Golden Biotechnology Corp
NAICS : 325411
SIC : 5122
ISIN : TW0004132006
Description
Golden Biotechnology Corp is a Taiwan based company engages in the production of drugs and herbal supplement. It specializes in anti-cancer and anti-atherosclerosis drugs.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.23 | |||||
| Equity-to-Asset | 0.66 | |||||
| Debt-to-Equity | 0.46 | |||||
| Debt-to-EBITDA | -1.89 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 6.15 | |||||
| Beneish M-Score | -1.66 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 29.3 | |||||
| 3-Year EBITDA Growth Rate | 5.9 | |||||
| 3-Year EPS without NRI Growth Rate | 7.7 | |||||
| 3-Year FCF Growth Rate | 2.4 | |||||
| 3-Year Book Growth Rate | -2.3 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.88 | |||||
| 9-Day RSI | 36.96 | |||||
| 14-Day RSI | 32.63 | |||||
| 6-1 Month Momentum % | -2.52 | |||||
| 12-1 Month Momentum % | -46.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.88 | |||||
| Quick Ratio | 1.58 | |||||
| Cash Ratio | 1.23 | |||||
| Days Inventory | 760.38 | |||||
| Days Sales Outstanding | 6.22 | |||||
| Days Payable | 3.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.3 | |||||
| Shareholder Yield % | -0.75 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 77.88 | |||||
| Operating Margin % | -120.01 | |||||
| Net Margin % | -111.55 | |||||
| FCF Margin % | -156 | |||||
| ROE % | -28.09 | |||||
| ROA % | -19.28 | |||||
| ROIC % | -32.99 | |||||
| ROC (Joel Greenblatt) % | -44.15 | |||||
| ROCE % | -26.1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 22.06 | |||||
| PB Ratio | 6.6 | |||||
| Price-to-Tangible-Book | 6.92 | |||||
| EV-to-EBIT | -20.01 | |||||
| EV-to-EBITDA | -27.04 | |||||
| EV-to-Revenue | 21.7 | |||||
| EV-to-FCF | -13.71 | |||||
| Price-to-Median-PS-Value | 0.49 | |||||
| Price-to-Net-Current-Asset-Value | 18.58 | |||||
| Price-to-Net-Cash | 125.22 | |||||
| Earnings Yield (Greenblatt) % | -5.01 | |||||
| FCF Yield % | -7.08 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Golden Biotechnology Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 185.787 | ||
| EPS (TTM) (NT$) | -1.461 | ||
| Beta | 1.31 | ||
| Volatility % | 57.79 | ||
| 14-Day RSI | 32.63 | ||
| 14-Day ATR (NT$) | 1.286551 | ||
| 20-Day SMA (NT$) | 29.51 | ||
| 12-1 Month Momentum % | -46.15 | ||
| 52-Week Range (NT$) | 27.6 - 71.4 | ||
| Shares Outstanding (Mil) | 142.23 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Golden Biotechnology Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Golden Biotechnology Corp Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Golden Biotechnology Corp Frequently Asked Questions
What is Golden Biotechnology Corp(ROCO:4132)'s stock price today?
The current price of ROCO:4132 is NT$28.80. The 52 week high of ROCO:4132 is NT$71.40 and 52 week low is NT$27.60.
When is next earnings date of Golden Biotechnology Corp(ROCO:4132)?
The next earnings date of Golden Biotechnology Corp(ROCO:4132) is .
Does Golden Biotechnology Corp(ROCO:4132) pay dividends? If so, how much?
Golden Biotechnology Corp(ROCO:4132) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers